title: Variable number of tandem repeats of TNF receptor type 2 promoter as genetic biomarker of susceptibility to develop invasive pulmonary aspergillosis.
abstract: Tumor necrosis factor alpha (TNF-alpha) and lymphotoxin alpha (LT-alpha) are pivotal mediators of inflammatory responses in fungal infection diseases. We hypothesized that polymorphisms in genes of these cytokines or their receptors might increase the susceptibility of hematologic patients to develop invasive pulmonary aspergillosis (IPA). One hundred two hematologic patients and 124 age-matched controls were enrolled in the study, and the following standard single nucleotide polymorphisms were investigated: TNF-alpha -308 and +489, LT-alpha +252 and Tumor Necrosis Factor Receptor 2 (TNFR2) +676. Variable number of tandem repeats (VNTRs) at position -322 of the TNFR2 gene were also studied. Genotypic and allelic frequencies were similar between patients and controls. IPA was diagnosed in 54 of the 102 patients according to consensus criteria published by the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group. TNF-alpha and LT-alpha polymorphisms were not associated with presence of IPA. Susceptibility to IPA was strongly associated with VNTR at position -322 in the promoter region of the TNR2 gene (p = 0.029) but was not associated with the presence of TNFR2 +676 polymorphism. A genetic difference in TNFR2 promoter VNTR may play a major role in susceptibility to IPA infection.
authors.affiliation: Unidad de Investigación, Servicio de Hematología, Hospital Universitario Virgen de las Nieves, Granada, Spain. jsainz@ugr.es
authors.forename: Juan
authors.initials: J
authors.lastname: Sainz
authors.forename: Eva
authors.initials: E
authors.lastname: Pérez
authors.forename: Laila
authors.initials: L
authors.lastname: Hassan
authors.forename: Antonio
authors.initials: A
authors.lastname: Moratalla
authors.forename: Antonio
authors.initials: A
authors.lastname: Romero
authors.forename: María Dolores
authors.initials: MD
authors.lastname: Collado
authors.forename: Manuel
authors.initials: M
authors.lastname: Jurado
mesh_terms: D001228:Aspergillosis / Q000235:genetics* / Q000378:metabolism* / Q000628:therapy; D005260:Female; D005819:Genetic Markers; D020022:Genetic Predisposition to Disease; D006801:Humans; D008172:Lung Diseases, Fungal / Q000235:genetics* / Q000378:metabolism* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D018598:Minisatellite Repeats / Q000235:genetics*; D011401:Promoter Regions, Genetic; D011446:Prospective Studies; D047889:Receptors, Tumor Necrosis Factor, Type II / Q000235:genetics*
chemical_list: D005819:Genetic Markers; D047889:Receptors, Tumor Necrosis Factor, Type II